Performance Overview of Supporting Curing Agent Manufacturers
The supporting curing agent industry in China plays a crucial role in providing essential components for various sectors. This article provides an overview of three prominent supporting curing agent production companies: Huangma Technology, Yangzhou Chenhua, and Wansheng Corporation. By examining their financial results and market trends, we can gain insights into the challenges and opportunities faced by the industry.
1. Huangma Technology (Polyetheramine):
In the first three quarters of 2023, Huangma Technology achieved total operating income of 1.406 billion yuan, representing an 18.31% year-on-year decrease. The net profit attributable to shareholders was 235 million yuan, down 38.01% compared to the previous year. However, in the third quarter, the company achieved operating income of 508 million yuan, a notable increase of 3.82%. The net profit attributable to shareholders also increased to 84.51 million yuan, a 3.14% year-on-year increase.
2. Yangzhou Chenhua (Polyetheramine):
During the first three quarters of 2023, Yangzhou Chenhua recorded approximately 718 million yuan in revenue, a decrease of 14.67% year-on-year. The net profit attributable to shareholders was around 39.08 million yuan, down 66.44% compared to the previous year. However, in the third quarter, the company achieved operating income of 254 million yuan, a notable increase of 3.31%. Despite this, the net profit attributable to shareholders reached only 16.32 million yuan, a decrease of 37.82%.
3. Wansheng Corporation:
Wansheng Corporation reported operating income of 2.163 billion yuan in the first three quarters of 2023, representing a 17.77% year-on-year decrease. The net profit was 165 million yuan, down 42.23% compared to the previous year. In the third quarter, the company achieved operating income of 738 million yuan, a decrease of 11.67%. However, the net profit attributable to shareholders increased to 48.93 million yuan, a 7.23% year-on-year increase.
The performance of supporting curing agent manufacturers in China has been influenced by various factors, including market conditions, pricing dynamics, and industry trends. While some companies experienced declines in operating income and net profit, others managed to achieve growth, albeit with varying degrees of success. The industry as a whole continues to navigate challenges and explore opportunities for improvement. By adapting to market demands, optimizing operations, and maintaining a competitive edge, supporting curing agent manufacturers can position themselves for sustained growth in the evolving business landscape.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
UAE Breaks Ground on World’s First Gigascale Round-the-Clock Renewable Energy Project, Setting a New Global Standard For Clean Energy
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
A White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for SurvivalA White Storm Sweeps Through “Golden October”: China’s Titanium Dioxide Giants Join Forces in a Battle for Survival
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Aspen Secures Approval to Market Lilly’s Mounjaro for Weight Loss in South Africa
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
Recommend Reading
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
EFSA Unable to Confirm Safety of Fusarium flavolapis Fungal Protein as a Novel Food
-
“Clearing the Floor”: DKSH’s Privatization of Its Malaysian Subsidiary Signals a Silent Power Shift in Asia’s Supply Chain
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
This week, the coke market in China was mainly weak.
-
Recent EVA Market Trend Continues to Be Weak in China
-
Business Society’s August 21, 2026 View on Isooctanol Market Trends: Clearly Upward
-
Sluggish Demand Sends Hydrogen Peroxide Market Down
-
Business Society’s Market Outlook for Formic Acid on August 21, 2026: Volatile